ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Acute lymphocytic leukaemia,Leukaemias acute lymphocytic,Leukaemias,Neopl,Y
2,1,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
3,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
3,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
4,3,Pneumonia fungal,Fungal infections NEC,Fungal infectious disorders,Infec,Y
5,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
6,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
7,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
9,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
9,3,Headache,Headaches NEC,Headaches,Nerv,N
10,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
11,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
11,2,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
12,1,Pancreatic cyst,Cystic pancreatic disorders,Exocrine pancreas conditions,Gastr,N
13,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
13,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
14,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
15,1,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
16,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
16,2,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
16,3,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
17,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
17,2,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
17,3,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
17,4,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
18,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
19,1,Blood bilirubin abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
19,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
20,1,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
20,2,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
21,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
21,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
22,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
23,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
24,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
25,1,Bone marrow transplant,Haematological therapeutic procedures NEC,Haematological and lymphoid tissue therapeutic procedures,Surg,N
26,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
26,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
26,3,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
27,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
27,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
27,3,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
28,1,Inflammatory marker increased,Chemistry analyses NEC,Protein and chemistry analyses NEC,Inv,N
28,2,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
28,3,Thyroiditis,Acute and chronic thyroiditis,Thyroid gland disorders,Endo,N
29,1,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
30,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
31,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
31,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
32,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
33,1,Empyema,Infections NEC,Infections - pathogen unspecified,Infec,N
33,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
33,3,Pleural infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
34,1,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
35,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
35,2,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
36,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
36,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
37,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
38,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
39,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
39,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
39,3,Orbitotomy,Orbit and globe therapeutic procedures,Eye therapeutic procedures,Surg,N
39,4,Plastic surgery to the face,Facial therapeutic procedures,Head and neck therapeutic procedures,Surg,N
39,5,Sinus operation,Paranasal therapeutic procedures,Head and neck therapeutic procedures,Surg,N
39,6,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
39,7,Trigeminal neuralgia,Trigeminal disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
39,8,Trigeminal neuralgia,Trigeminal disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
40,1,Aspergilloma,Aspergillus infections,Fungal infectious disorders,Infec,N
40,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
40,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
40,4,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
40,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
40,6,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
40,7,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
41,1,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
42,1,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
42,2,Duodenal stenosis,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
42,3,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
42,4,Gastrectomy,Gastric therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
42,5,Incorrect dosage administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
42,6,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
42,7,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
43,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
43,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
43,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
44,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
44,2,Heart transplant,Cardiac therapeutic procedures NEC,Cardiac therapeutic procedures,Surg,N
45,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
46,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
47,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
47,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
48,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
48,2,Leg amputation,Limb therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
49,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
50,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
50,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
51,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
52,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
53,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
54,1,Bone marrow transplant,Haematological therapeutic procedures NEC,Haematological and lymphoid tissue therapeutic procedures,Surg,N
54,2,Headache,Headaches NEC,Headaches,Nerv,N
54,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
54,4,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
54,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
55,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
56,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
57,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
58,1,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
59,1,Mucormycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
59,2,Product dosage form confusion,Product confusion errors and issues,Medication errors and other product use errors and issues,Inj&P,N
59,3,Product dosage form confusion,Product confusion errors and issues,Medication errors and other product use errors and issues,Inj&P,N
59,4,Product label issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
59,5,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
60,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,Y
60,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
60,3,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
60,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
60,5,Mucormycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
60,6,Transplant,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
61,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
61,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
62,1,Cardioactive drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
62,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
62,3,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
62,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
63,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
64,1,Dose calculation error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
64,2,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
65,1,Aphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
65,2,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
65,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
65,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
66,1,Lower respiratory tract infection fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
67,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
68,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
69,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
70,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
71,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
72,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
72,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
72,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
72,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
72,5,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
73,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
74,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
75,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
75,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
76,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
76,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
76,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
77,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
77,2,Circumstance or information capable of leading to medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
78,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
79,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
80,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
80,2,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
81,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
82,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
83,1,Drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,Y
84,1,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
85,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
86,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
86,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
86,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
87,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
88,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
88,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
89,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
90,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
91,1,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
92,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
93,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
94,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
95,1,Transplant,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
96,1,Mucormycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
97,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
98,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
98,2,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
99,1,Acanthamoeba keratitis,Amoebic infections,Protozoal infectious disorders,Infec,N
99,2,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
99,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
99,4,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
100,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
100,2,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
101,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
101,2,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
101,3,Incorrect product dosage form administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
102,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
103,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
103,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
103,3,Neuropsychological symptoms,Mental disorders due to a general medical condition NEC,Psychiatric disorders NEC,Psych,N
103,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
104,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
104,2,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
104,3,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
105,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
106,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
106,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
106,3,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
106,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
106,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
107,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
107,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
107,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
107,4,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
107,5,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
108,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
109,1,Bursitis,Bursal disorders,Synovial and bursal disorders,Musc,N
109,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
110,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
110,2,Incorrect product formulation administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
110,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
111,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
112,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
113,1,Alkalosis,Metabolic alkaloses,Acid-base disorders,Metab,N
113,2,Cortisol decreased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
113,3,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
113,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
113,5,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
113,6,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
113,7,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
113,8,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
114,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
114,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
115,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
115,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
115,3,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
115,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
115,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
115,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
116,1,Blood potassium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
117,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
118,1,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
118,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
119,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
120,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
120,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
120,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
120,4,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
120,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
121,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
122,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
122,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
123,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
123,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
124,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
124,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
124,3,Scedosporium infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
125,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
125,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
125,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
125,4,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
126,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
126,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
127,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
127,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
127,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
127,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
128,1,Blood product transfusion dependent,Disability issues,Lifestyle issues,SocCi,N
128,2,Chondrocalcinosis,Crystal arthropathic disorders,Joint disorders,Musc,N
128,3,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
128,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
129,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
129,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
129,3,Scedosporium infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
130,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
131,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
131,2,Brain abscess,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
131,3,Enterococcal infection,Enterococcal infections,Bacterial infectious disorders,Infec,N
131,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
131,5,Phaeohyphomycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
132,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
133,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
133,2,Brain abscess,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
133,3,Enterococcal infection,Enterococcal infections,Bacterial infectious disorders,Infec,N
133,4,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
133,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
133,6,Phaeohyphomycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
134,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
135,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
136,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
136,2,Flavobacterium infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
136,3,Fusarium infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
136,4,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
136,5,Respiratory syncytial virus infection,Respiratory syncytial viral infections,Viral infectious disorders,Infec,N
137,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
137,2,Flavobacterium infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
137,3,Fusarium infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
137,4,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
137,5,Respiratory syncytial virus infection,Respiratory syncytial viral infections,Viral infectious disorders,Infec,N
138,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
138,2,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
138,3,Flavobacterium infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
138,4,Fusarium infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
138,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
138,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
138,7,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
138,8,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
138,9,Respiratory syncytial virus infection,Respiratory syncytial viral infections,Viral infectious disorders,Infec,N
139,1,11-beta-hydroxylase deficiency,Inborn errors of steroid synthesis,Metabolic and nutritional disorders congenital,Cong,N
139,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
139,3,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
139,4,Secondary hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
140,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
141,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
142,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
143,1,11-beta-hydroxylase deficiency,Inborn errors of steroid synthesis,Metabolic and nutritional disorders congenital,Cong,N
143,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
143,3,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
143,4,Secondary hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
144,1,Choking sensation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
144,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
144,3,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
144,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
144,5,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
145,1,Aortic aneurysm,Aortic aneurysms and dissections,Aneurysms and artery dissections,Vasc,N
146,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
147,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
147,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
148,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
148,2,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
149,1,Antimicrobial susceptibility test resistant,Microbiology and serology tests NEC,Microbiology and serology investigations,Inv,N
150,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
150,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
150,3,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
151,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
151,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
151,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
151,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
151,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
151,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
151,7,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
152,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
153,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
153,2,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
153,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
154,1,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
155,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
156,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
157,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
158,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
159,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
160,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
161,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
161,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
162,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
162,2,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
163,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
163,2,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
164,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
165,1,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
165,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
165,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
165,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
165,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
166,1,Immunosuppressant drug level,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
166,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
167,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
167,2,Immunosuppressant drug level,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
168,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
168,2,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
168,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
169,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
170,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
170,2,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
170,3,Flavobacterium infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
170,4,Fusarium infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
170,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
170,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
170,7,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
170,8,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
170,9,Respiratory syncytial virus infection,Respiratory syncytial viral infections,Viral infectious disorders,Infec,N
171,1,11-beta-hydroxylase deficiency,Inborn errors of steroid synthesis,Metabolic and nutritional disorders congenital,Cong,N
171,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
171,3,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
171,4,Secondary hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
172,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
173,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
173,2,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
173,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
174,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
174,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
174,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
175,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
175,2,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
175,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
175,4,Fusarium infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
175,5,Respiratory syncytial virus infection,Respiratory syncytial viral infections,Viral infectious disorders,Infec,N
176,1,Coating in mouth,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
176,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
176,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
176,4,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
177,1,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
178,1,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
179,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
179,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
179,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
179,4,Vaccination site pain,Vaccination site reactions,Administration site reactions,Genrl,N
179,5,Vaccination site swelling,Vaccination site reactions,Administration site reactions,Genrl,N
180,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
181,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
182,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
183,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
184,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
184,2,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
184,3,Flavobacterium infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
184,4,Fusarium infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
184,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
184,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
184,7,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
184,8,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
184,9,Respiratory syncytial virus infection,Respiratory syncytial viral infections,Viral infectious disorders,Infec,N
185,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
185,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
186,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
186,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
187,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
187,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
187,3,Oral toxicity,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
188,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
189,1,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
190,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
190,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
190,3,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
190,4,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
190,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
190,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
191,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
191,2,Headache,Headaches NEC,Headaches,Nerv,N
191,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
191,4,Lip blister,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
191,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
191,6,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
191,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
192,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
192,2,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
193,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
194,1,Drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
194,2,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
194,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
195,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
196,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
197,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
197,2,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
198,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
199,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,Y
199,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
199,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
199,4,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
199,5,Exophthalmos,"Structural change, deposit and degeneration of eye NEC","Ocular structural change, deposit and degeneration NEC",Eye,N
199,6,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
199,7,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
199,8,Necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
199,9,Ophthalmoplegia,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
199,10,Palate injury,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
200,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
200,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
200,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
200,4,Klebsiella bacteraemia,Klebsiella infections,Bacterial infectious disorders,Infec,Y
200,5,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
201,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
201,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
202,1,Therapeutic product ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
203,1,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
204,1,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
205,1,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,Y
206,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
206,2,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
207,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
207,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
208,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
209,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
209,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
209,3,Fat tissue decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
209,4,General physical condition abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
209,5,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
210,1,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
211,1,Brain natriuretic peptide abnormal,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
211,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
211,3,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
211,4,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
211,5,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
212,1,Pseudoaldosteronism,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
213,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
213,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
213,3,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
214,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
215,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
216,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
216,2,Drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
216,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
